Display options
Cite
Kostakoglu L. Variables Involved in Measuring Cancer Response to Treatment. PET Clin. 2008;3(1):13-36doi: 10.1016/j.cpet.2008.08.002.
Kostakoglu, L. (2008). Variables Involved in Measuring Cancer Response to Treatment. PET clinics, 3(1), 13-36. https://doi.org/10.1016/j.cpet.2008.08.002
Kostakoglu, Lale. "Variables Involved in Measuring Cancer Response to Treatment." PET clinics vol. 3,1 (2008): 13-36. doi: https://doi.org/10.1016/j.cpet.2008.08.002
Kostakoglu L. Variables Involved in Measuring Cancer Response to Treatment. PET Clin. 2008 Jan;3(1):13-36. doi: 10.1016/j.cpet.2008.08.002. Epub 2008 Nov 27. PMID: 27158145.
Copy Download .nbib Format: NLM
Share it on

PET Clin. 2008 Jan;3(1):13-36. doi: 10.1016/j.cpet.2008.08.002. Epub 2008 Nov 27.

Variables Involved in Measuring Cancer Response to Treatment.

PET clinics

Lale Kostakoglu

Affiliations

  1. PET/CT Oncology and Research, Division of Nuclear Medicine, Department of Radiology, Mount Sinai Medical Center, One Gustave Levy Place, Box 1141, New York, NY 10029, USA. Electronic address: [email protected].

PMID: 27158145 DOI: 10.1016/j.cpet.2008.08.002

Abstract

In this article, the discussions about concepts involved in anticancer therapy, including cell death pathways and the variables that guide clinical management, such as intents and types of anticancer therapy regimens and modalities, are a prelude to the review of FDG PET/CT imaging parameters used in the evaluation of response to therapy. The review also includes brief discussions about differences between evaluation of cytostatic and cytotoxic therapy regimens and induction and neoadjuvant therapy regimens.

Published by Elsevier Inc.

Keywords: Cancer therapy; FDG-PET; Therapy response

Publication Types